Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2004 May 15;380(Pt 1):131–137. doi: 10.1042/BJ20031880

Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.

Christopher J Endres 1, Dhruba J Sengupta 1, Jashvant D Unadkat 1
PMCID: PMC1224139  PMID: 14759222

Abstract

We developed a yeast-based assay for selection of hENT1 (human equilibrative nucleoside transporter 1) mutants that have altered affinity for hENT1 inhibitors and substrates. In this assay, expression of hENT1 in a yeast strain deficient in adenine biosynthesis (ade2) permits yeast growth on a plate lacking adenine but containing adenosine, a hENT1 substrate. This growth was prevented when inhibitors of hENT1 [e.g. NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside], dilazep or dipyridamole] were included in the media. To identify hENT1 mutants resistant to inhibition by these compounds, hENT1 was randomly mutagenized and introduced into this strain. Mutation(s) that allowed growth of yeast cells in the presence of these inhibitors were then identified and characterized. Mutants harbouring amino acid changes at Leu92 exhibited resistance to NBMPR and dilazep but not dipyridamole. The IC50 values of NBMPR and dilazep for [3H]adenosine transport by one of these mutants L92Q (Leu92-->Gln) were approx. 200- and 4-fold greater when compared with the value for the wild-type hENT1, whereas that for dipyridamole remained unchanged. Additionally, when compared with the wild-type transporter, [3H]adenosine transport by L92Q transporter was significantly resistant to inhibition by inosine and guanosine but not by adenosine or pyrimidines. The Km value for inosine transport was approx. 4-fold greater for the L92Q mutant (260+/-16 mM) when compared with the wild-type transporter (65+/-7.8 mM). We have identified for the first time an amino acid residue (Leu92) of hENT1 that, when mutated, selectively alters the affinity of hENT1 to transport the nucleosides inosine and guanosine and its sensitivity to the inhibitors NBMPR and dilazep.

Full Text

The Full Text of this article is available as a PDF (185.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acimovic Yugo, Coe Imogen R. Molecular evolution of the equilibrative nucleoside transporter family: identification of novel family members in prokaryotes and eukaryotes. Mol Biol Evol. 2002 Dec;19(12):2199–2210. doi: 10.1093/oxfordjournals.molbev.a004044. [DOI] [PubMed] [Google Scholar]
  2. Balimane PV, Sinko PJ. Involvement of multiple transporters in the oral absorption of nucleoside analogues. Adv Drug Deliv Rev. 1999 Oct 18;39(1-3):183–209. doi: 10.1016/s0169-409x(99)00026-5. [DOI] [PubMed] [Google Scholar]
  3. Cadwell R. C., Joyce G. F. Randomization of genes by PCR mutagenesis. PCR Methods Appl. 1992 Aug;2(1):28–33. doi: 10.1101/gr.2.1.28. [DOI] [PubMed] [Google Scholar]
  4. Chandrasena G., Giltay R., Patil S. D., Bakken A., Unadkat J. D. Functional expression of human intestinal Na+-dependent and Na+-independent nucleoside transporters in Xenopus laevis oocytes. Biochem Pharmacol. 1997 Jun 15;53(12):1909–1918. doi: 10.1016/s0006-2952(97)00170-6. [DOI] [PubMed] [Google Scholar]
  5. Che M., Ortiz D. F., Arias I. M. Primary structure and functional expression of a cDNA encoding the bile canalicular, purine-specific Na(+)-nucleoside cotransporter. J Biol Chem. 1995 Jun 9;270(23):13596–13599. doi: 10.1074/jbc.270.23.13596. [DOI] [PubMed] [Google Scholar]
  6. Chenu C., Berteloot A. Allosterism and Na(+)-D-glucose cotransport kinetics in rabbit jejunal vesicles: compatibility with mixed positive and negative cooperativities in a homo- dimeric or tetrameric structure and experimental evidence for only one transport protein involved. J Membr Biol. 1993 Mar;132(2):95–113. doi: 10.1007/BF00239000. [DOI] [PubMed] [Google Scholar]
  7. Crawford C. R., Cass C. E., Young J. D., Belt J. A. Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell line. Biochem Cell Biol. 1998;76(5):843–851. doi: 10.1139/bcb-76-5-843. [DOI] [PubMed] [Google Scholar]
  8. Duflot Sylvie, Calvo Maria, Casado F. Javier, Enrich Carlos, Pastor-Anglada Marçal. Concentrative nucleoside transporter (rCNT1) is targeted to the apical membrane through the hepatic transcytotic pathway. Exp Cell Res. 2002 Nov 15;281(1):77–85. doi: 10.1006/excr.2002.5641. [DOI] [PubMed] [Google Scholar]
  9. Flanagan S. A., Meckling-Gill K. A. Characterization of a novel Na+-dependent, guanosine-specific, nitrobenzylthioinosine-sensitive transporter in acute promyelocytic leukemia cells. J Biol Chem. 1997 Jul 18;272(29):18026–18032. doi: 10.1074/jbc.272.29.18026. [DOI] [PubMed] [Google Scholar]
  10. Graham K. A., Leithoff J., Coe I. R., Mowles D., Mackey J. R., Young J. D., Cass C. E. Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1. Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb;19(1-2):415–434. doi: 10.1080/15257770008033018. [DOI] [PubMed] [Google Scholar]
  11. Griffith D. A., Jarvis S. M. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta. 1996 Oct 29;1286(3):153–181. doi: 10.1016/s0304-4157(96)00008-1. [DOI] [PubMed] [Google Scholar]
  12. Griffiths M., Beaumont N., Yao S. Y., Sundaram M., Boumah C. E., Davies A., Kwong F. Y., Coe I., Cass C. E., Young J. D. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med. 1997 Jan;3(1):89–93. doi: 10.1038/nm0197-89. [DOI] [PubMed] [Google Scholar]
  13. Hoffman C. S., Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene. 1987;57(2-3):267–272. doi: 10.1016/0378-1119(87)90131-4. [DOI] [PubMed] [Google Scholar]
  14. Huang Q. Q., Yao S. Y., Ritzel M. W., Paterson A. R., Cass C. E., Young J. D. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J Biol Chem. 1994 Jul 8;269(27):17757–17760. [PubMed] [Google Scholar]
  15. Hyde R. J., Cass C. E., Young J. D., Baldwin S. A. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol. 2001 Jan-Mar;18(1):53–63. [PubMed] [Google Scholar]
  16. Jarvis S. M., Thorn J. A., Glue P. Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters. Br J Pharmacol. 1998 Apr;123(8):1587–1592. doi: 10.1038/sj.bjp.0701775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lai Yurong, Bakken Aimee H., Unadkat Jashvant D. Simultaneous expression of hCNT1-CFP and hENT1-YFP in Madin-Darby canine kidney cells. Localization and vectorial transport studies. J Biol Chem. 2002 Jul 3;277(40):37711–37717. doi: 10.1074/jbc.M204986200. [DOI] [PubMed] [Google Scholar]
  18. Mackey J. R., Mani R. S., Selner M., Mowles D., Young J. D., Belt J. A., Crawford C. R., Cass C. E. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. 1998 Oct 1;58(19):4349–4357. [PubMed] [Google Scholar]
  19. Malo C., Berteloot A. Analysis of kinetic data in transport studies: new insights from kinetic studies of Na(+)-D-glucose cotransport in human intestinal brush-border membrane vesicles using a fast sampling, rapid filtration apparatus. J Membr Biol. 1991 Jun;122(2):127–141. doi: 10.1007/BF01872636. [DOI] [PubMed] [Google Scholar]
  20. Mangravite L. M., Lipschutz J. H., Mostov K. E., Giacomini K. M. Localization of GFP-tagged concentrative nucleoside transporters in a renal polarized epithelial cell line. Am J Physiol Renal Physiol. 2001 May;280(5):F879–F885. doi: 10.1152/ajprenal.2001.280.5.F879. [DOI] [PubMed] [Google Scholar]
  21. Mäser P., Sütterlin C., Kralli A., Kaminsky R. A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Science. 1999 Jul 9;285(5425):242–244. doi: 10.1126/science.285.5425.242. [DOI] [PubMed] [Google Scholar]
  22. Plagemann P. G., Wohlhueter R. M., Woffendin C. Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta. 1988 Oct 11;947(3):405–443. doi: 10.1016/0304-4157(88)90002-0. [DOI] [PubMed] [Google Scholar]
  23. Ritzel M. W., Ng A. M., Yao S. Y., Graham K., Loewen S. K., Smith K. M., Ritzel R. G., Mowles D. A., Carpenter P., Chen X. Z. Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem. 2000 Oct 13;276(4):2914–2927. doi: 10.1074/jbc.M007746200. [DOI] [PubMed] [Google Scholar]
  24. Schiestl R. H., Gietz R. D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet. 1989 Dec;16(5-6):339–346. doi: 10.1007/BF00340712. [DOI] [PubMed] [Google Scholar]
  25. SenGupta Dhruba J., Lum Pek Y., Lai Yurong, Shubochkina Elena, Bakken Aimee H., Schneider Glenda, Unadkat Jashvant D. A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine. Biochemistry. 2002 Feb 5;41(5):1512–1519. doi: 10.1021/bi015833w. [DOI] [PubMed] [Google Scholar]
  26. SenGupta Dhruba J., Unadkat Jashvant D. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep. Biochem Pharmacol. 2004 Feb 1;67(3):453–458. doi: 10.1016/j.bcp.2003.09.018. [DOI] [PubMed] [Google Scholar]
  27. Sundaram M., Yao S. Y., Ingram J. C., Berry Z. A., Abidi F., Cass C. E., Baldwin S. A., Young J. D. Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs. J Biol Chem. 2001 Oct 2;276(48):45270–45275. doi: 10.1074/jbc.M107169200. [DOI] [PubMed] [Google Scholar]
  28. Sundaram M., Yao S. Y., Ng A. M., Cass C. E., Baldwin S. A., Young J. D. Equilibrative nucleoside transporters: mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins. Biochemistry. 2001 Jul 10;40(27):8146–8151. doi: 10.1021/bi0101805. [DOI] [PubMed] [Google Scholar]
  29. Sundaram M., Yao S. Y., Ng A. M., Griffiths M., Cass C. E., Baldwin S. A., Young J. D. Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J Biol Chem. 1998 Aug 21;273(34):21519–21525. doi: 10.1074/jbc.273.34.21519. [DOI] [PubMed] [Google Scholar]
  30. Thorn J. A., Jarvis S. M. Adenosine transporters. Gen Pharmacol. 1996 Jun;27(4):613–620. doi: 10.1016/0306-3623(95)02053-5. [DOI] [PubMed] [Google Scholar]
  31. Vickers M. F., Mani R. S., Sundaram M., Hogue D. L., Young J. D., Baldwin S. A., Cass C. E. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q). Biochem J. 1999 Apr 1;339(Pt 1):21–32. [PMC free article] [PubMed] [Google Scholar]
  32. Vickers M. F., Young J. D., Baldwin S. A., Ellison M. J., Cass C. E. Functional production of mammalian concentrative nucleoside transporters in Saccharomyces cerevisiae. Mol Membr Biol. 2001 Jan-Mar;18(1):73–79. [PubMed] [Google Scholar]
  33. Visser Frank, Vickers Mark F., Ng Amy M. L., Baldwin Stephen A., Young James D., Cass Carol E. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole. J Biol Chem. 2001 Oct 31;277(1):395–401. doi: 10.1074/jbc.M105324200. [DOI] [PubMed] [Google Scholar]
  34. Wang J., Schaner M. E., Thomassen S., Su S. F., Piquette-Miller M., Giacomini K. M. Functional and molecular characteristics of Na(+)-dependent nucleoside transporters. Pharm Res. 1997 Nov;14(11):1524–1532. doi: 10.1023/a:1012113931332. [DOI] [PubMed] [Google Scholar]
  35. Ward J. L., Sherali A., Mo Z. P., Tse C. M. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem. 2000 Mar 24;275(12):8375–8381. doi: 10.1074/jbc.275.12.8375. [DOI] [PubMed] [Google Scholar]
  36. Yao S. Y., Ng A. M., Muzyka W. R., Griffiths M., Cass C. E., Baldwin S. A., Young J. D. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem. 1997 Nov 7;272(45):28423–28430. doi: 10.1074/jbc.272.45.28423. [DOI] [PubMed] [Google Scholar]
  37. Yao Sylvia Y. M., Ng Amy M. L., Vickers Mark F., Sundaram Manickavasagam, Cass Carol E., Baldwin Stephen A., Young James D. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation. J Biol Chem. 2002 May 2;277(28):24938–24948. doi: 10.1074/jbc.M200966200. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES